Modified Prophylactic Donor Lymphocyte Infusion (DLI) in an Adult T Cell Lymphoma/Leukemia (ATLL) Patient—Modality of Relapse Prevention

Adult T-cell Leukemia/Lymphoma (ATLL) is a rare but aggressive malignancy associated with the human T-cell lymphotropic virus type 1 (HTLV-1). ATLL is a challenging malignancy characterized by its aggressive nature and poor prognosis. Despite advancements in treatment, relapse rates remain high. Don...

Full description

Bibliographic Details

Published in:	Diseases
Main Authors:	Alexandra Ionete, Alexandru Bardas, Zsofia Varady, Madalina Vasilica, Orsolya Szegedi, Daniel Coriu
Format:	Article
Language:	English
Published:	MDPI AG 2024-09-01
Subjects:	donor lymphocyte infusion (DLI) adult T-cell leukemia/lymphoma (ATLL) allogeneic stem cell transplantation prophylactic DLI stem cell transplantation (HSCT) post-transplant cyclophosphamide (PTCy)
Online Access:	https://www.mdpi.com/2079-9721/12/9/210